News About: Pharm. Industry
MetaBio Registers Novel Drug Sensitivity Test Method to National Health Insurance
MetaBio Co., a domestic biotechnology venture company specialized in cancer treatments and related business, recently announced that the company's drug sensitivity test method for cancer patients has been registered t...
CJ Launches Chronic Renal Failure Medication
CJ Pharmaceutical Division announced this week that the company makes an official launching of chronic renal failure medication Kremezin in the domestic market starting February 1st, under the exclusive promotion cont...
Clorox Korea Generates 55.8 Billion Won of Revenue, 4.16 Billion Won of Net Profit
Clorox Korea Ltd., a wholly owned domestic subsidiary of the Clorox International Company, announced that it recorded the total revenue of 55.8 billion won for the 14th annual fiscal period ending June 30th, 2004.
...
Heightened Competition Expected As Manufacturers Make New Product Introductions
A number of domestic pharmaceutical firms are attempting to boost their sales by introducing a number of brand new products to the market, estimated at twenty new items or more per each pharmaceutical company.
The ...
Elevated Recognition Toward Technology Specialists and Their Importance
While the majority of domestic pharmaceutical firms continue to focus on the development of specialized resources that would address their immediate business requirements, the industry is gradually recognizing an impo...
Wyeth Korea Sets Revenue Plan at 87 Billion Won
Wyeth Korea has established its current year revenue plan at 87 billion won, continuing its strong growth momentum from the last year's revenue of 72.8 billion won, which was up 43% from Year 2003.
The company expe...
Novel Antimicrobial Agent Regarded as Next-Generation Antibiotics
Cellbiotech Co, a domestic biotechnology venture company, recently announced that its joint clinical study with a pharmaceutical company from China has produced favorable results from using a novel antimicrobial agent...
Boehringer Ingelheim Introduces COPD Treatment in Domestic Market
Boehringer Ingelheim Korea and Pfizer Korea announced that Spiriva HandiHaler (tiotropium bromide), for the treatment of COPD (Chronic Obstructive Pulmonary Disease), will be available in the domestic market starting ...
Choongwae Enters Competitive Hyperlipidemia Treatment Market
Choongwae Pharmaceutical enters the domestic hyperlipidemia treatment market valued over 100 billion won by obtaining the market approval for Livalo, an original drug co-developed by Japan's Kowa Yakuhin and Nissan Ch...
MSD Korea's Cholesterol Absorption Inhibitor Now Available
Six months after obtaining a market approval by the Korea Food and Drug Administration (KFDA), MSD Korea officially announced that Ezetrol, a cholesterol absorption inhibitor, is now available in the domestic market. ...
